Replies to post #34562 on Intellipharmaceutics International Inc. (IPCI)

[bluelucky]

Seems like it has to be the potential for good podras results and then selling off the platform.

What makes absolutely no sense is why the large work force remains.


What is 100% clear is that current business plan is broken beyond repair.

Why do they continue to throw money down the drain

[doogdilinger]

Yep why they insist on not doing anything about their failed generics pipeline is far beyond me...but an adaptable/visionary company would recognize the disaster their generics pipeline has become and find some way to off load it to begin funding real advancement in their stagnant PODRAS, Regabatin and Rexista pipeline progress.

There's simply no excuse for no advancement on anything they've spent 10's of millions of dollars developing over the past 8 and a half years only to be on track for less than a million dollars in revenue this year.

If PAR's lost market share on FocalinXR how much is it worth to them right now to buy the rights to it?

If MNK's not interested in growing SeroquelXR sales then why not end the failed licensing agreement with them and sell off the SeroquelXR rights to someone who will try to generate revenue growth with it?

If the market completely passed them by on Glucophage and Keppra why not sell the rights to both to a far more established bio to at least get something back for all the bonuses paid and the 10's of millions of dollars spent developing both.

If the FDA isn't approving any of their other remaining generics then clearly after all these years of efforts it's time to move on and at least try to start unlocking some of the potential inherent value out of their PODRAS tech or their Rexista and Regabatin NDA candidates.

The lack of them being able to secure a partner on Regabatin or Rexista for that matter speaks volumes about what potential big partners really think of this mgmt. team and how much potential inherent value either of those 2 NDA candidates really possess. And at this point I honestly don't know why Dr. Odidi continues to insist on not drastically changing his approach instead of doing the same things that landed IPCI here in the 1st place.

I genuinely fear that the only true super star IPCI ever had was the original CFO Shameze, and ever since he departed the scene for far greener pastures this stocks once great potential of 4 years ago has completely cratered leaving it on life support...and the retail shareholders bitter and feeling completely betrayed by a mgmt. team that appears to have no answers on how to reverse course and salvage the once great potential of 4 years ago

[wimuskyfisherman]

Fabius and Blue- I said a few weeks ago I thought IPCI gets bought out at $50M. That is the end game.